Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Abingdon Health PLC ( (GB:ABDX) ) has provided an update.
Abingdon Health PLC has secured a significant contract valued at approximately US$2.5 million with a global pharmaceutical company for the development and regulatory approval of a companion diagnostic lateral flow point of care test. This contract highlights the strength of Abingdon Health’s CDMO services, which provide comprehensive support from concept to commercial success. The company’s recent acquisitions and the launch of a new performance evaluation laboratory have enhanced its capabilities, making it a preferred partner for clients seeking integrated diagnostic and therapeutic development solutions.
Spark’s Take on GB:ABDX Stock
According to Spark, TipRanks’ AI Analyst, GB:ABDX is a Neutral.
Abingdon Health PLC’s overall stock score is influenced by its significant revenue growth and strategic partnerships. However, ongoing profitability challenges and negative free cash flow weigh heavily against its financial performance. The technical analysis shows mild upward momentum, but the valuation reflects the company’s current unprofitability, balancing the positive impacts of recent corporate events.
To see Spark’s full report on GB:ABDX stock, click here.
More about Abingdon Health PLC
Abingdon Health Group is a leading med-tech contract service provider offering services to an international customer base. The company’s CDMO division specializes in lateral flow product development, regulatory support, technology transfer, and manufacturing services, particularly in infectious disease, clinical testing, companion diagnostics, animal health, and environmental testing. Abingdon Health also provides a range of regulatory services through its subsidiaries Compliance Solutions (Life Sciences) and IVDeology, and offers an e-commerce platform for self-tests under the Abingdon Simply Test range.
Average Trading Volume: 77,947
Technical Sentiment Signal: Strong Sell
Current Market Cap: £12.1M
For an in-depth examination of ABDX stock, go to TipRanks’ Overview page.